INTEGRA LIFESCIENCES HOLDINGS CORP(IART)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IART at 48.2/100 on a 32-signal composite quality model, placing it at rank #1,739 of 2,960 stocks — the bottom half of the AI-ranked universe. IART scores in the top quartile across earnings quality (97.4). Areas of concern include institutional flow (15.1) and free cash flow (30.9), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), INTEGRA LIFESCIENCES HOLDINGS CORP reports quarterly revenue of $418.8M, net income of $4.5M, an operating margin of 4.6%. Top institutional holders of IART by reported 13-F value include BlackRock, Rubric Capital Management, Invesco Ltd., based on the most recent SEC filings. IART trades on the Nasdaq exchange and files with the SEC under CIK 917520. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IART daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for INTEGRA LIFESCIENCES HOLDINGS CORP directly from SEC EDGAR.